Dunfermline firm Optos eyes strong rise in sales

Optos sells eye-testing machines that can detect high blood pressure and some cancers

Retinal imaging company Optos is eyeing a big rise in turnover for the year after reporting strong sales in the last quarter.

The company said revenues for the year to 30 September should exceed $190m (£118m) - ahead of market expectations.

Its performance was boosted by sales of its newly developed ultra-wide field retinal scanner Daytona.

Dunfermline-based Optos sells eye-testing machines that can detect high blood pressure and some cancers.

In a trading update, the firm said the number of installed core Optos ultra-wide field products had risen by 11% in the year to 4,700.

A total of 329 Daytona devices were installed at the end of September.

Optos also expects operating profit to be "slightly above market consensus".

Chief executive Roy Davis commented: "I am delighted with the company's achievements this year and, in particular, the manufacturing scale-up and market roll-out of Daytona.

"The reaction to this instrument has been very positive and I am excited by the opportunities it brings to the business.

"Our near-term focus is to drive sales of Daytona in all our key markets and to continue our success with the 200Tx instrument in the ophthalmology market."